Relavo

Relavo is a medical device startup focused on improving the lives of kidney failure patients by making home dialysis safer and more accessible. The company was founded by a team of female biomedical engineers from Johns Hopkins University. Their primary product, the PeritoneX, is designed to minimize the risk of infection during peritoneal dialysis (PD), a treatment for kidney failure that can be administered at home.

PD is a less utilized treatment option, with only 10% of kidney failure patients receiving it, largely due to the risk of infection. Peritonitis, an infection of the peritoneal membrane, is a common complication caused by bacteria entering the body during the treatment setup. Relavo's PeritoneX aims to reduce this risk by preventing bacteria from entering the patient's body during the dialysis process.

The PeritoneX is compatible with existing PD systems and has shown promising results in laboratory settings, achieving a significant reduction in peritonitis-causing bacteria. This not only makes home dialysis safer but also reduces the risk of secondary contamination as patients can receive treatment with the connector still in place.

Relavo operates in the medical device market, specifically targeting kidney failure patients who require dialysis. Their business model revolves around the sales of the PeritoneX device, which is designed to make home dialysis a more viable and safer option for patients.

Keywords: Medical Device, Kidney Failure, Home Dialysis, Peritoneal Dialysis, Infection Prevention, PeritoneX, Biomedical Engineering, Johns Hopkins University, Female-Founded, Patient Safety.